China Enables Cross-Region Health Insurance Reimbursement
This article was originally published in PharmAsia News
Cross-region health insurance reimbursement is no longer an impossibility in some Chinese cities like Shanghai and Nantong, putting an end to the decades-long issue of patients commuting between two regions to obtain their insurance reimbursements
You may also be interested in...
Mylan, in partnership with Indian firm Lupin, will be looking to rival Biogen and Sandoz by introducing an etanercept biosimilar in European markets following a positive opinion by the EMA’s CHMP on Mylan's application.
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.
Which drug candidates represent hope, and which hype? The Scrip team examine the COVID-19 pipeline, lessons from China, and some long term impacts on the sector.